Technicians don't like to read the papers, so Greg Harmon is looking at the action in big cap...
Technicians don't like to read the papers, so Greg Harmon is looking at the action in big cap pharma stocks and it's telling him they're going to like the outcome of the Supreme Court ruling on Obamacare. Bristol-Myers (BMY), Eli Lilly (LLY), Merck (MRK), and Pfizer (PFE) - all yielding nearly 4% or more - are all on the verge of long-term breakouts.
From other sites
Bristol Myers Squibb : OPINION: From the Editor: Fill Your Bucket List Foundation grants wishes to adult cancer patientsat 4-traders.com (Tue, 7:19PM)
at Benzinga.com (Feb 26, 2015)
at Benzinga.com (Feb 25, 2015)
at CNBC.com (Feb 17, 2015)
at Investor's Business Daily (Jan 27, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs